Hawaii reports dozens of acute non-viral hepatitis cases linked to dietary supplement, OxyElite Pro

The Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) and Hawaii state health officials are investigating some 29 cases of acute non-viral hepatitis with an unknown cause.

OxyElite Pro
Image/Video Screen Shot

The Hawaii Department of Health (DOH), as part of their investigation, says two dozen (83%) of these cases share a common link to a dietary supplement product labeled as OxyElite Pro.

The FDA reports that eleven of the 29 cases have been hospitalized with acute hepatitis, two cases have received liver transplants and one person has died.

The FDA advises consumers to stop using any dietary supplement products labeled as OxyElite Pro while the investigation continues. OxyElite Pro is distributed by USPlabs LLC of Dallas, Texas, and is sold nation-wide through a wide range of distribution channels, including the internet and retail stores that sell dietary supplements.

USPlabs LLC has informed the FDA that it will voluntarily cease distributing OxyElite Pro as the company cooperates with the investigation.

In addition, the FDA is investigating whether counterfeit OxyElite Pro may be a source of the hepatitis cases after USPlabs LLC informed the agency of that suspicion.

Symptoms of all types of hepatitis are similar and can include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay or gray-colored bowel movements, joint pain, yellow eyes, and jaundice.

The CDC is advising physicians evaluating patients with acute hepatitis to ask about consumption of dietary supplements as part of a comprehensive evaluation.

Looking for a job in health care? Check here to see what’s available